In lieu of its annual conference that was scheduled for November 9 but delayed until early 2022, Life Science Tennessee (LST) is hosting a virtual event focused on biomarkers that day.
The discussion under the title of “Biomarkers and Revolutions in Patient Care” will explore key policy issues facing our industry in the upcoming legislative session with a focus on biomarkers. Speakers representing biotech companies, patient advocacy groups, researchers, and more will discuss how we can work together to advance new treatments and cures and support the continued growth of our industry in Tennessee, particularly for innovative life science start-ups.
In addition to policy insights, the event will also include dedicated time to network with other LST members in a virtual event hall. Here’s the agenda:
- “Biomarkers and Revolutions in Patient Care” will feature a panel exploring the benefits of genome and exome sequencing to recognize different health challenges, including cancer, and the push for public and private insurers to cover the cost of this sequencing to support diagnostics. Panelists will also address expected state legislation meant to address the costs of sequencing slated for the next session.
- “Home-grown Tech: An SBIR Success Story” will feature Justin Baba, Chief Scientific officer at Yaya Scientific, discussing his start-up journey and how the Small Business Innovation Research matching funds program has accelerated the company’s development.
- LST updates and Board vote: We will provide other updates on our legislative agenda and activities this year.
To register for the event that runs 12 noon to 2 p.m. EST and will be delivered by Lunchpool, click here.